In liver cancer, patients have a poor prognosis with high GSN expression, possibly because GSN overexpression increases the aggressiveness of cancer cells via controlling epithelial-mesenchymal transition (EMT) (Zhang et al., 2020b). The gene discussed is GSN; the disease is cancer.